Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zinc oxide broad spectrum UVB/UVA sunblock efficacy substantiated -- FDA.

This article was originally published in The Tan Sheet

Executive Summary

ZINC OXIDE 2%-25% BROAD SPECTRUM SUNSCREEN EFFICACY SUBSTANTIATED, FDA concludes in Nov. 4 letters to sunscreen manufacturer Johnson & Johnson and ingredient suppliers Haarmann & Reimer, SunSmart and Tioxide America. Responding to studies filed by the companies in support of Category I (safe and effective) classification for zinc oxide, FDA states: "The submitted studies provide sufficient evidence that zinc oxide blocks UV radiation in both the UVB and UVA range of wavelengths."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel